Early detection of high-grade squamous intraepithelial lesions in the cervix with quantitative spectroscopic imaging
Quantitative spectroscopy has recently been extended from a contact-probe to wide-area spectroscopic imaging to enable mapping of optical properties across a wide area of tissue. We train quantitative spectroscopic imaging (QSI) to identify cervical high-grade squamous intraepithelial lesions (HSILs...
Saved in:
Published in | Journal of biomedical optics Vol. 18; no. 7; p. 076013 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Society of Photo-Optical Instrumentation Engineers
01.07.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Quantitative spectroscopy has recently been extended from a contact-probe to wide-area spectroscopic imaging to enable mapping of optical properties across a wide area of tissue. We train quantitative spectroscopic imaging (QSI) to identify cervical high-grade squamous intraepithelial lesions (HSILs) in 34 subjects undergoing the loop electrosurgical excision procedure (LEEP subjects). QSI's performance is then prospectively evaluated on the clinically suspicious biopsy sites from 47 subjects undergoing colposcopic-directed biopsy. The results show the per-subject normalized reduced scattering coefficient at 700 nm (An) and the total hemoglobin concentration are significantly different (p<0.05) between HSIL and non-HSIL sites in LEEP subjects. An alone retrospectively distinguishes HSIL from non-HSIL with 89% sensitivity and 83% specificity. It alone applied prospectively on the biopsy sites distinguishes HSIL from non-HSIL with 81% sensitivity and 78% specificity. The findings of this study agree with those of an earlier contact-probe study, validating the robustness of QSI, and specifically An, for identifying HSIL. The performance of An suggests an easy to use and an inexpensive to manufacture monochromatic instrument is capable of early cervical cancer detection, which could be used as a screening and diagnostic tool for detecting cervical cancer in low resource countries. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present affiliation: Hong Kong University of Science and Technology, Division of Biomedical Engineering, Kowloon, Hong Kong SAR, China. Author is deceased. Present affiliation: Brigham and Women’s Hospital, Department of Pathology, Boston, Massachusetts 02115. Present affiliation: University of California, Department of Chemistry, Berkeley, California 94709. Present affiliation: Canon U.S.A., Inc., Optics Research Laboratory, 9030 South Rita Road, Suite 302, Tucson, Arizona 85747. |
ISSN: | 1083-3668 1560-2281 1560-2281 |
DOI: | 10.1117/1.JBO.18.7.076013 |